pcos semaglutide vs. Tirzepatide for CUAnschutz researchers have published a
Description
GLP-1 receptor agonists act on a single incretin pathwaythe GLP-1 pathwayto regulate blood sugar and appetite
It represents all the "bad" types of cholesterol, including LDL and other lipoproteins that can contribute to plaque build-up in the arteries
Heidenreich et al., 2022
112 This protective effect was seen only with GLP-1 receptor agonists and not with other diabetes drugs
The main reason comes down to cost
While compounded formulations are prepared in FDA-regulated pharmacies, the FDA does not verify their safety or effectiveness
